TEM Earnings

TEM reported its earnings on 2026-05-05, showcasing a revenue of 348.12M against an estimate of 345.51M, resulting in a 0.75% surprise. The EPS was -0.13, surpassing the expected -0.2 by 35%. The stock experienced a -1.05% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TEM's earnings announcement on 2026-05-05, the stock price moved by -1.05% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, TEM's stock price tends to shift by an average of -1.01% in the 10 days leading up to earnings and -4.45% in the 10 days following, providing insight into potential market.

For , analysts estimate TEM's annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TEM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TEM's stock price typically moves by -1.01% in the 10 days before its earnings and -4.45% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call reveals strong financial performance, particularly in data licensing, with a 44% growth and major partnerships with Merck and Gilead. Despite some uncertainties in FDA submissions, the company anticipates significant revenue growth driven by oncology and AI solutions. Positive cash flow projections and strategic collaborations further enhance sentiment. The market's positive response to strategic partnerships and robust financial metrics outweighs any minor uncertainties, indicating a likely positive stock movement in the short term.